Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADA 2021
Biotech
Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues
Hanmi's GLP-1 drug reduced the risk of heart attack, stroke and death as well as the decline in patients’ kidney function, new data show.
Amirah Al Idrus
Jun 28, 2021 5:19pm
ADA: Medtronic’s InPen keeps diabetes patients in target range
Jun 28, 2021 1:01pm
ADA: Senseonics shows off accuracy for 180-day glucose sensor
Jun 28, 2021 11:44am
ADA: TB vaccine restores key immune cells in Type 1 diabetes
Jun 28, 2021 10:35am
ADA: Insulet's new Omnipod shows gains in preschoolers with T1D
Jun 28, 2021 9:20am
Lilly's next-gen GLP-1 cuts blood sugar in early-stage diabetes
Jun 26, 2021 4:15pm
